Covered recipient · General Payments record
NEIL Q TRAN
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$33,456.08
- Reported across 886 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,568.78 | 132 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $334.93 | 15 |
| Lilly USA, LLC | $273.05 | 21 |
| Novo Nordisk AS | $229.57 | 15 |
| Amgen Inc. | $220.55 | 11 |
| Insulet Corporation | $191.15 | 7 |
| ABBVIE INC. | $187.00 | 10 |
| SANOFI-AVENTIS U.S. LLC | $124.06 | 6 |
| Embecta Corp. | $100.10 | 4 |
| Xeris Pharmaceuticals, Inc. | $91.11 | 4 |
| Corcept Therapeutics | $91.03 | 3 |
| RECORDATI_RARE_DISEASES_INC. | $67.07 | 3 |
| Tandem Diabetes Care, Inc. | $66.54 | 3 |
| Verity Pharmaceuticals Inc. | $58.20 | 2 |
| DEXCOM, INC. | $50.34 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $48.74 | 2 |
| Radius Health, Inc. | $47.59 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $41.68 | 2 |
| BETA BIONICS, INC. | $40.62 | 4 |
| MannKind Corporation | $39.28 | 2 |
| GlaxoSmithKline, LLC. | $37.32 | 2 |
| Acerta Pharma LLC | $34.77 | 2 |
| CeQur Corporation | $34.44 | 1 |
| Kyowa Kirin, Inc. | $33.79 | 2 |
| Medtronic, Inc. | $23.02 | 1 |
| Exact Sciences Corporation | $20.02 | 1 |
| Alexion Pharmaceuticals, Inc. | $19.06 | 1 |
| Alvogen Inc | $17.13 | 1 |
| Antares Pharma, Inc. | $16.94 | 1 |
| TOLMAR, INC. | $16.22 | 1 |
| Currax Pharmaceuticals LLC | $13.46 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (132)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.